riboflavin
FDA Approved
Description
Riboflavin (vitamin B2) is a precursor to flavin cofactors essential for mitochondrial electron transport chain function. High-dose riboflavin has shown therapeutic benefit in certain mitochondrial disorders and organic acidurias by enhancing residual enzyme activity. It is particularly studied in mitochondrial DNA depletion syndromes and complex I deficiencies.
Indications & Therapeutic Use
riboflavin deficiency, mitochondrial disorders, complex I deficiency, organic acidurias
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
riboflavin
| Generic Name | riboflavin |
| Brands | 1 brand available |
| Active Ingredient | riboflavin |
| Drug Class | riboflavin deficiency |
| Manufacturer | Various |
| Dosage Forms | oral tablet, 50-400mg |
| Medical Code | A11HA04 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT03678519 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes